Epigenetic acquisition of inducibility of type III cytotoxicity in P. aeruginosa

BMC Bioinformatics

Volumn 7, Issue , 2006, Pages

  Filopon, Didier ^a   Mérieau, Annabelle ^b   Bernot, Gilles ^c   Comet, Jean Paul ^c   LeBerre, Rozenne ^d   Guery, Benoit ^d   Polack, Benoit ^a   Guespin Michel, Janine ^b  

^a GRENOBLE UNIVERSITY HOSPITAL   (France)

^b UNIVERSITÉ DE ROUEN   (France)

^c UNIVERSITÉ D EVRY VAL D ESSONNE   (France)

^d France Institut Pasteur de Lille   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC RESISTANCE; CHRONIC LUNG DISEASE; MATHEMATICAL FRAMEWORKS; MECHANICAL VENTILATION; PSEUDOMONAS AERUGINOSA; PULMONARY INFECTIONS; THERAPEUTIC STRATEGY; TYPE III SECRETION SYSTEM;

BACTERIA; METABOLITES; PHYSIOLOGY; STRAIN; VENTILATION;

CYTOTOXICITY;

BACTERIAL TOXIN; EXOPOLYSACCHARIDE; EXSA PROTEIN; REGULATOR PROTEIN; UNCLASSIFIED DRUG; BACTERIAL PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL PNEUMONIA; BACTERIAL VIRULENCE; BIOFILM; CALCIUM DEPLETION; CHRONIC LUNG DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMPUTER MODEL; COMPUTER PROGRAM; CONTROLLED STUDY; CYSTIC FIBROSIS; CYTOTOXICITY; ENCAPSULATION; EPIGENETICS; GENE EXPRESSION; GENOTYPE PHENOTYPE CORRELATION; GRAM NEGATIVE INFECTION; HERITABILITY; HOST PATHOGEN INTERACTION; IN VIVO STUDY; MATHEMATICAL COMPUTING; MORBIDITY; MORTALITY; MUTATIONAL ANALYSIS; NEUTROPENIA; NONHUMAN; OPPORTUNISTIC INFECTION; PHENOTYPIC VARIATION; POSITIVE FEEDBACK; PSEUDOMONAS AERUGINOSA; RAT; REGULATORY MECHANISM; VALIDATION STUDY; VENTILATOR ASSOCIATED PNEUMONIA; BIOLOGICAL MODEL; COMPUTER SIMULATION; GENETIC EPIGENESIS; GENETIC PREDISPOSITION; GENETICS; HUMAN; PHENOTYPE; PSEUDOMONAS INFECTION;

PSEUDOMONAS AERUGINOSA;

BACTERIAL PROTEINS; COMPUTER SIMULATION; EPIGENESIS, GENETIC; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MODELS, GENETIC; PHENOTYPE; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS;

EID: 33745767500     PISSN: 14712105     EISSN: 14712105     Source Type: Journal    
DOI: 10.1186/1471-2105-7-272     Document Type: Article

References (43)

1. Govan JR, Harris GS: Pseudomonas aeruginosa and cystic fibrosis: unusual bacterial adaptation and pathogenesis. Microbiol Sci 1986, 3:302-308.
2. Hueck CJ: Type III protein secretion systems in bacterial pathogens of animals and plants. Microbiol Mol Biol Rev 1998, 62:379-433.
3. Frank DW: The exoenzyme S regulon of Pseudomonas aeruginosa. Mol Microbiol 1997, 26:621-629.
4. McCaw ML, Lykken GL, Singh PK, Yahr TL: ExsD is a negative regulator of the Pseudomonas aeruginosa type III secretion regulon. Mol Microbiol 2002, 46:1123-1133.
5. Dasgupta N, Lykken GL, Wolfgang MC, Yahr TL A novel anti-anti-activator mechanism regulates expression of the Pseudomonas aeruginosa type III secretion system. Mol Microbiol 2004, 53:297-308.
6. Rietsch A, Vallet-Gely I, Dove SL, Mekalanos JJ: ExsE, a secreted regulator of type III secretion genes in Pseudomonas aeruginosa. Proc Natl Acad Sci U S A 2005, 102:8006-8011.
7. Urbanowski ML, Lykken GL, Yahr TL: A secreted regulatory protein couples transcription to the secretory activity of the Pseudomonas aeruginosa type III secretion system. Proc Natl Acad Sci U S A 2005, 102:9930-9935.
8. Dacheux D, Attree I, Toussaint B. Expression of ExsA in trans confers type III secretion system-dependent cytotoxicity on noncytotoxic Pseudomonas aeruginosa cystic fibrosis isolates. Infect Immun 2001, 69:538-542.
9. Jain M, Ramirez D, Seshadri R, Cullina JF, Powers CA, Schulert GS, Bar-Meir M, Sullivan CL, McColley SA, Hauser AR. Type III secretion phenotypes of Pseudomonas aeruginosa strains change during infection of individuals with cystic fibrosis. J Clin Microbiol 2004, 42:5229-5237.
10. Novick A, Wiener M: Enzyme induction is an all-or-none phenomenon. Proc Natl Acad Sci USA 1957, 43:553-556.
11. Cohn M, Horibata K. Inhibition by glucose of the induced synthesis of the b-galactoside-enzyme system of Eschercichia coli. Analysis of maintenance. J Bacteriol 1959, 78:601-611.
12. Ozbudak EM, Thattai M, Lim HN, Shraiman BI, van Oudenaarden A. Multistability in the lactose utilization network of Escherichia coli. Nature 2004, 19;427:737-740.
13. Thomas R: On the relation between the logical structure of systems and their ability to generate multiple steady states or sustained oscillations. Springer Series in Synergies 1980, 9:180-193.
14. Thomas R: Laws for the dynamics of regulatory networks. Int J Dev Biol 1998, 42:479-485.
15. Soulé C: Graphic requierement for multistationarity. Com-PlexUs 2003, 1:123-133.
16. Angeli D, Ferrell JEJ, Sontag ED: Detection of multistability, bifurcations, and hysteresis in a large class of biological positive-feedback systems. Proc Natl Acad Sci U S A 2004, 101:1822-1827.
17. Kaufman M, Thomas R: Emergence of complex behaviour from simple circuit structures. C R Biol 2003, 326:205-214.
18. Snoussi EH, Thomas R: Logical identification of all steady states: the concept of feedback loop characteristics states. Bull Math Biol 1993, 57:277-297.
19. Thomas R, d'Ari R. Biological feedback CRC Press; 1990.
20. Guespin-Michel JE, Kaufman M: Positive feedback circuits and adaptive regulations in bacteria. Acta Biotheor 2001, 49:207-218.
21. Bernot G, Comet JP, Richard A, Guespin J: Application of formal methods to biological regulatory networks: extending Thomas' asynchronous logical approach with temporal logic. J Theor Biol 2004, 229:339-347.
22. Stark MJ: Multicopy expression vectors carrying the lac repressor gene for regulated high-level expression of genes in Escherichia coli. Gene 1987, 51:255-267.
23. Dacheux D, Attree I, Schneider C, Toussaint B: Cell death of human polymorphonuclear neutrophils induced by a Pseudomonas aeruginosa cystic fibrosis isolate requires a functional type III secretion system. Infect Immun 1999, 67:6164-6167.
24. Roy-Burman A, Savel RH, Racine S, Swanson BL, Revadigar NS, Fujimoto J, Sawa T, Frank DW, Wiener-Kronish JP: Type III Protein Secretion Is Associated with Death in Lower Respiratory and Systemic Pseudomonas aeruginosa. Infections. J Infect Dis 2001, 183:1767-1774.
25. Hauser AR, Cobb E, Bodi M, Mariscal D, Vallés J, Engel JN, Rello J: Type III protein secretion is associated with poor clinical outcomes in patients with ventilator-associated pneumonia caused by Pseudomonas aeruginosa. Crit Care Med 2002, 30:521-528.
26. Ader F, Le Berre R, Faure K, Gosset P, Epaulard O, Toussaint B, Polack B, Nowak E, Viget NB, Kipnis E, Guery BP: Alveolar Response to Pseudomonas aeruginosa: Role of the Type III Secretion System. Infect Immun 2005, 73:4263-4271.
27. Ozbudak EM, Thattai M, Kurtser I, Grossman AD, van Oudenaarden A: Regulation of noise in the expression of a single gene. Nat Genet 2002, 31:69-73.
28. Arkin A, Ross J, McAdams HH: Stochastic kinetic analysis of developmental pathway bifurcation in phage lambdainfected Escherichia coli cells. Genetics 1998, 149:1633-1648.
29. Rietsch A, Mekalanos JJ: Metabolic regulation of type III secretion gene expression in Pseudomonas aeruginosa. Mol Microbiol 2006, 59:807-820.
30. Bleves S, Soscia C, Nogueira-Orlandi P, Lazdunski A, Filloux A: Quorum sensing negatively controls type III secretion regulon expression in Pseudomonas aeruginosa PAOI. J Bacteriol 2005, 187:3898-3902.
31. Hogardt M, Roeder M, Schreff AM, Eberl L, Heesemann J: Expression of Pseudomonas aeruginosa exoS is controlled by quorum sensing and RpoS. Microbiology 2004, 150:843-851.
32. Nordfelth R, Kauppi AM, Norberg HA, Wolf-Watz H, Elofsson M: Small-molecule inhibitors specifically targeting type III secretion. Infect Immun 2005, 73:3104-3114.
33. Hassett DJ, Cuppoletti J, Trapnell B, Lymar SV, Rowe JJ, Yoon SS, Hilliard GM, Parvatiyar K, Kamani MC, Wozniak Dj, Hwang SH, McDermott TR, Ochsner UA: Anaerobic metabolism and quorum sensing by Pseudomonas aeruginosa biofilms in chronically infected cystic fibrosis airways: rethinking antibiotic treatment strategies and drug targets. Adv Drug Deliv Rev 2002, 54:1425-1443.
34. Vance RE, Rietsch A, Mekalanos JJ: Role of the type III secreted exoenzymes S, T, and Y in systemic spread of Pseudomonas aeruginosa PAOI in vivo. Infect Immun 2005, 73:1706-1713.
35. Corech R, Rao A, Laxova A, Moss J, Rock MJ, Li Z, Kosorok MR, Splaingard ML, Farrell PM, Barbieri JT: Early immune response to the components of the type III system of Pseudomonas aeruginosa in children with cystic fibrosis. J Clin Microbiol 2005, 43:3956-3962.
36. Toussaint B, Delic-Attree I, Vignais PM: Pseudomonas aeruginosa contains an IHF-like protein that binds to the algD promoter. Biochem Biophys Res Commun 1993, 196:416-421.
37. Quenee L, Lamotte D, Polack B. Combined sacB-based negative selection and cre-lox antibiotic marker recycling for efficient gene deletion in pseudomonas aeruginosa. Biotechniques 2005, 38:63-67.
38. West SEH, Schweizer HP, Dall C, Sample AK, Runyen-Janecky LJ: Construction of improved Escherichia-Pseudomonas shuttle vectors derived from pUC18/19 and sequence of the region required for their replication in Pseudomonas aeruginosa. Gene 1994, 128:81-86.
39. Pseudomonas Genome Project 2006 [http://www.pseudomonas.com.
40. Hovey AK, Frank DW: Analyses of the DNA-binding and transcriptional activation properties of ExsA, the transcriptional activator of the Pseudomonas aeruginosa exoenzyme S regulon. J Bacteriol 1995, 177:4427-4436.
41. Pennington JE, Ehrie MG: Pathogenesis of Pseudomonas aeruginosa pneumonia during immunosuppression. J Infect Dis 1978, 137:764-774.
42. Viget NB, Guery BP, Ader F, Neviere R, Alfandari S, Creuzy C, Roussel-Delvallez M, Foucher C, Mason CM, Beaucaire G, Pittet JF: Keratinocyte growth factor protects against Pseudomonas aeruginosa-induced lung injury. Am J Physiol Lung Cell Mol Physiol 2000, 279:L1199-L1209.
43. Le Berre R, Faure K, Fauvel H, Viget NB, Ader F, Prangere T, Thomas AM, Leroy X, Pittet JF, Marchetti P, Guery BP. Apoptosis inhibition in P. aeruginosa-induced lung injury influences lung fluid balance. Intensive Care Med 2004, 30:1204-1211.